On a quest to revive Southern California's kelp forests, divers tackle the invasive purple urchin threat. Discover how their efforts are transforming underwater ecosystems and supporting marine life.
Jurassic World Rebirth has taken the box office by storm, earning $26.3M on July 4th alone and surpassing previous franchise records. With a 5-day total of $141.2M, this film is a must-see this summer!
Jurassic World Rebirth has taken the international box office by storm, raking in $26M from 38 markets on its opening day, plus $30.5M domestically for a grand total of $56.5M globally. China leads with a record $9.9M launch!
In a dramatic legal twist, Paramount Global has settled a $16 million lawsuit with Donald Trump over a CBS interview with Kamala Harris, with funds directed to Trump's future presidential library. This settlement raises questions about media accountability and political influence.
Fortnite players are set to receive over $126 million in refunds due to unwanted in-game charges. Learn how to file your claim before the deadline approaches!
Exciting news for Apple fans! The Apple Watch Series 10 is now available in the refurbished store, offering significant savings. Find out why you might want to consider buying refurbished from Apple!
A remarkable discovery at the Natural History Museum of Utah reveals a 76-million-year-old lizard fossil, offering insights into ancient ecosystems and the evolution of Gila monsters. This rare find, named Bolg amondol, sheds light on the diverse prehistoric wildlife of Utah.
Disney’s Lilo & Stitch continues its box office success, nearing $800M globally. Meanwhile, Mission: Impossible – The Final Reckoning and Lionsgate’s Ballerina also make headlines in the competitive movie landscape.
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
In a surprising turn of events, Regeneron has announced its acquisition of 23andMe for $256 million following the company's bankruptcy. The pharma giant aims to leverage 23andMe's vast customer data for drug discovery while prioritizing privacy and security.
